Innovative Strategies in Cancer Treatment
This annual cancer conference honors the memory of Marjean Reed.
If you are attending online, please register at https://attendee.gotowebinar.com/register/7565727772844083714.
Des Moines University students, staff, and faculty, physicians, nurses, social workers, other medical professionals, healthcare community, and families who have been affected by cancer.
Clinical oncology is a rapidly evolving field characterized by continual advances in cancer detection, diagnosis, and treatment. With the advent of advanced imaging, genomic profiling, and targeted molecular therapies, today’s healthcare providers are equipped to battle cancer in more ways than ever before.
By developing an awareness of this ever-expanding field, healthcare providers will be able to direct their patients toward the latest treatment modalities and to gain insight into future directions within the field. Doing so provides an opportunity to improve the quality of care for cancer patients and to advance the continual battle against this once-devastating disease.
- List and describe the variety of emerging treatment modalities available to patients.
- Recognize the role of each oncology subspecialty in the advancement of cancer treatment.
- Discuss the direction of future cancer research efforts.
Melanoma as a Model in Innovation in Cancer Care
Mohammed Milhem, M.B.,B.S., University of Iowa Hospitals and Clinics
Cancer Panel Discussion
Mohammed M. Milhem, M.B.,B.S.
Clinical Associate Professor of Internal Medicine - Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa; Deputy Director of Clinical Services at the Holden Comprehensive Cancer Center; Director of Melanoma and Sarcoma Program, University of Iowa
- M.B.,B.S, Jordan University, Amman, Jordan
- Internship, Palestine Hospital, Amman, Jordan
- Internship, Al-Bashir Hospital, Amman, Jordan
- Internal Medicine Residency, University of Illinois at Chicago
- Hematology/Oncology Fellowship, University of Illinois at Chicago
- Bone Marrow Transplant Fellowship, University of Illinois at Chicago
Dr. Milhem indicated he has no financial relationships to disclose relevant to the content of this CME activity.
Cancer Panel Members
Charles Goldman, M.D., FACS
Oncologist, Mercy Surgical Affiliates
Dr. Goldman has over 18 years experience in the treatment of cancers throughout the body, including those of the esophagus, stomach, breast, skin, and the soft tissue (sarcomas), and in the integration of chemotherapy and radiation in the treatment of these cancers. During that time, he has taught cancer surgery to surgical residents at university hospitals in Minnesota, California and West Virginia. He is presently director of the Mercy Medical Center surgical residency, vice-chairman of the North Central Cancer Group (Mayo Clinic) surgery committee, and lead investigator in research into the protein expression of various tumor types. Dr. Goldman is an active member of the American College of Surgeons, the American Society of Clinical Oncology, IORA, and other surgical education associations.
Andrew Nish, M.D.
Vascular and Interventional Radiologist, Iowa Radiology, P.C.
Originally from Elgin, Illinois, Dr. Nish is a graduate of Carleton College and the University of Chicago Medical School. He completed a residency in diagnostic radiology and a fellowship in interventional radiology at Henry Ford Hospital in Michigan. When not focused on vascular and interventional radiology, Dr. Nish enjoys bicycling and gardening.
There is no cost to attend but registration is strongly encouraged.
- If you are attending online, please register at https://attendee.gotowebinar.com/register/7565727772844083714.
- If you are attending at DMU, please complete the registration form below.
Educational grants are not being accepted for this activity.
ACCME: This activity has been planned and implemented in accordance with ACCME® Essential Areas and Elements and Iowa Medical Society (IMS) policies. Des Moines University is accredited by the IMS to provide continuing medical education for physicians. Des Moines University designates this live education activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AOA: This activity has been planned and implemented in accordance with the essential areas and policies of the American Osteopathic Association (AOA). Des Moines University is accredited by the AOA and approves this live activity for a maximum of 2.5 hours of AOA Category 2-A CME credits.
IBON: Des Moines University Continuing Medical Education (provider #112) is approved by the Iowa Board of Nursing as an accredited provider. This program has been reviewed and approved for 3.0 continuing education contact hours. Nurses must attend the entire activity to receive credit.
Other: This live activity is designated for 2.50 AMA PRA Category 1 Credits™.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. DMU CME adheres to ACCME Standards regarding industry support of continuing medical education. Disclosure of faculty and commercial sponsor relationships (if any) will be made known at the activity.
Des Moines University (DMU) prohibits discrimination in employment, educational programs, and activities on the basis of race, national origin, color, creed, religion, sex, age, disability, veteran status, sexual orientation, gender identity, or associational preference. The University also affirms its commitment to providing equal opportunities and equal access to University facilities. Individuals with disabilities are encouraged to attend DMU sponsored activities. If you have questions/concerns, please contact the DMU CME office at 515-271-1596 or email@example.com.